98 related articles for article (PubMed ID: 28863455)
1. Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood.
Amani V; Donson AM; Lummus SC; Prince EW; Griesinger AM; Witt DA; Hankinson TC; Handler MH; Dorris K; Vibhakar R; Foreman NK; Hoffman LM
J Neuropathol Exp Neurol; 2017 Jul; 76(7):595-604. PubMed ID: 28863455
[TBL] [Abstract][Full Text] [Related]
2. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
Godfraind C; Kaczmarska JM; Kocak M; Dalton J; Wright KD; Sanford RA; Boop FA; Gajjar A; Merchant TE; Ellison DW
Acta Neuropathol; 2012 Aug; 124(2):247-57. PubMed ID: 22526017
[TBL] [Abstract][Full Text] [Related]
3. Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study.
Donson AM; Bertrand KC; Riemondy KA; Gao D; Zhuang Y; Sanford B; Norris GA; Chapman RJ; Fu R; Willard N; Griesinger AM; Ribeiro de Sousa G; Amani V; Grimaldo E; Hankinson TC; Booker F; Sill M; Grundy RG; Pajtler KW; Ellison DW; Foreman NK; Ritzmann TA
Neuro Oncol; 2023 Oct; 25(10):1854-1867. PubMed ID: 37246777
[TBL] [Abstract][Full Text] [Related]
4. Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.
Griesinger AM; Calzadilla AJ; Grimaldo E; Donson AM; Amani V; Pierce AM; Steiner J; Kargar S; Serkova NJ; Bertrand KC; Wright KD; Vibhakar R; Hankinson T; Handler M; Lindsay HB; Foreman NK; Dorris K
Clin Cancer Res; 2024 Apr; 30(8):1544-1554. PubMed ID: 38334950
[TBL] [Abstract][Full Text] [Related]
5. Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma.
Hoffman LM; Donson AM; Nakachi I; Griesinger AM; Birks DK; Amani V; Hemenway MS; Liu AK; Wang M; Hankinson TC; Handler MH; Foreman NK
Acta Neuropathol; 2014 May; 127(5):731-45. PubMed ID: 24240813
[TBL] [Abstract][Full Text] [Related]
6. Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology.
Gödicke S; Kresbach C; Ehlert M; Obrecht D; Altendorf L; Hack K; von Hoff K; Carén H; Melcher V; Kerl K; Englinger B; Filbin M; Pajtler KW; Gojo J; Pietsch T; Rutkowski S; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):23. PubMed ID: 38265527
[TBL] [Abstract][Full Text] [Related]
7. Imaging features to distinguish posterior fossa ependymoma subgroups.
Leclerc T; Levy R; Tauziède-Espariat A; Roux CJ; Beccaria K; Blauwblomme T; Puget S; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Bolle S; Roux A; Pallud J; Provost C; Oppenheim C; Varlet P; Boddaert N; Dangouloff-Ros V
Eur Radiol; 2024 Mar; 34(3):1534-1544. PubMed ID: 37658900
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.
Neyazi S; Yamazawa E; Hack K; Tanaka S; Nagae G; Kresbach C; Umeda T; Eckhardt A; Tatsuno K; Pohl L; Hana T; Bockmayr M; Kim P; Dorostkar MM; Takami T; Obrecht D; Takai K; Suwala AK; Komori T; Godbole S; Wefers AK; Otani R; Neumann JE; Higuchi F; Schweizer L; Nakanishi Y; Monoranu CM; Takami H; Engertsberger L; Yamada K; Ruf V; Nomura M; Mohme T; Mukasa A; Herms J; Takayanagi S; Mynarek M; Matsuura R; Lamszus K; Ishii K; Kluwe L; Imai H; von Deimling A; Koike T; Benesch M; Kushihara Y; Snuderl M; Nambu S; Frank S; Omura T; Hagel C; Kugasawa K; Mautner VF; Ichimura K; Rutkowski S; Aburatani H; Saito N; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):22. PubMed ID: 38265489
[TBL] [Abstract][Full Text] [Related]
9. Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
Chapman RJ; Ghasemi DR; Andreiuolo F; Zschernack V; Espariat AT; Buttarelli FR; Giangaspero F; Grill J; Haberler C; Paine SML; Scott I; Jacques TS; Sill M; Pfister S; Kilday JP; Leblond P; Massimino M; Witt H; Modena P; Varlet P; Pietsch T; Grundy RG; Pajtler KW; Ritzmann TA
Neuro Oncol; 2023 Oct; 25(10):1871-1882. PubMed ID: 36916248
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.
Hirose Y; Aldape K; Bollen A; James CD; Brat D; Lamborn K; Berger M; Feuerstein BG
Am J Pathol; 2001 Mar; 158(3):1137-43. PubMed ID: 11238062
[TBL] [Abstract][Full Text] [Related]
11. Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma.
Zhang C; Ostrom QT; Semmes EC; Ramaswamy V; Hansen HM; Morimoto L; de Smith AJ; Pekmezci M; Vaksman Z; Hakonarson H; Diskin SJ; Metayer C; ; Taylor MD; Wiemels JL; Bondy ML; Walsh KM
Acta Neuropathol Commun; 2020 Oct; 8(1):173. PubMed ID: 33115534
[TBL] [Abstract][Full Text] [Related]
12. Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas.
Pohl LC; Leitheiser M; Obrecht D; Schweizer L; Wefers AK; Eckhardt A; Raffeld M; Sturm D; Pajtler KW; Rutkowski S; Fukuoka K; Ichimura K; Bockmayr M; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):24. PubMed ID: 38265522
[TBL] [Abstract][Full Text] [Related]
13. 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Okonechnikov K; Camgöz A; Chapman O; Wani S; Park DE; Hübner JM; Chakraborty A; Pagadala M; Bump R; Chandran S; Kraft K; Acuna-Hidalgo R; Reid D; Sikkink K; Mauermann M; Juarez EF; Jenseit A; Robinson JT; Pajtler KW; Milde T; Jäger N; Fiesel P; Morgan L; Sridhar S; Coufal NG; Levy M; Malicki D; Hobbs C; Kingsmore S; Nahas S; Snuderl M; Crawford J; Wechsler-Reya RJ; Davidson TB; Cotter J; Michaiel G; Fleischhack G; Mundlos S; Schmitt A; Carter H; Michealraj KA; Kumar SA; Taylor MD; Rich J; Buchholz F; Mesirov JP; Pfister SM; Ay F; Dixon JR; Kool M; Chavez L
Nat Commun; 2023 Apr; 14(1):2300. PubMed ID: 37085539
[TBL] [Abstract][Full Text] [Related]
14.
Whitehouse JP; Hii H; Mayoh C; Wong M; Ajuyah P; Barahona P; Cui L; Dholaria H; White CL; Buntine MK; Byrne J; Rodrigues da Silva K; Howlett M; Girard EJ; Tsoli M; Ziegler DS; Dyke JM; Lee S; Ekert PG; Cowley MJ; Gottardo NG; Endersby R
Front Oncol; 2023; 13():1123492. PubMed ID: 36937401
[TBL] [Abstract][Full Text] [Related]
15. Recurrent ACVR1 mutations in posterior fossa ependymoma.
Pratt D; Lucas CG; Selvam PP; Abdullaev Z; Ketchum C; Quezado M; Armstrong TS; Gilbert MR; Papanicolau-Sengos A; Raffeld M; Choo-Wosoba H; Chan P; Whipple N; Nasrallah M; Santi M; Ramaswamy V; Giannini C; Ritzmann TA; Grundy RG; Burford A; Jones C; Hawkins C; Venneti S; Solomon DA; Aldape K
Acta Neuropathol; 2022 Aug; 144(2):373-376. PubMed ID: 35587280
[No Abstract] [Full Text] [Related]
16. Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma.
Fu R; Norris GA; Willard N; Griesinger AM; Riemondy KA; Amani V; Grimaldo E; Harris F; Hankinson TC; Mitra S; Ritzmann TA; Grundy RR; Foreman NK; Donson AM
Neuro Oncol; 2023 Apr; 25(4):786-798. PubMed ID: 36215273
[TBL] [Abstract][Full Text] [Related]
17. An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes.
Mohankumar KM; Currle DS; White E; Boulos N; Dapper J; Eden C; Nimmervoll B; Thiruvenkatam R; Connelly M; Kranenburg TA; Neale G; Olsen S; Wang YD; Finkelstein D; Wright K; Gupta K; Ellison DW; Thomas AO; Gilbertson RJ
Nat Genet; 2015 Aug; 47(8):878-87. PubMed ID: 26075792
[TBL] [Abstract][Full Text] [Related]
18. No safe harbors for recurrent posterior fossa group A ependymoma: A time for change in risk assignment?
Hansford JR; Eisenstat DD
Neuro Oncol; 2023 Oct; 25(10):1868-1870. PubMed ID: 37487035
[No Abstract] [Full Text] [Related]
19. Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma.
Griesinger AM; Riemondy K; Eswaran N; Donson AM; Willard N; Prince EW; Paine SML; Bowes G; Rheaume J; Chapman RJ; Ramage J; Jackson A; Grundy RG; Foreman NK; Ritzmann TA
iScience; 2023 Sep; 26(9):107585. PubMed ID: 37694144
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, molecular classification and WHO grading of ependymoma.
Hübner JM; Kool M; Pfister SM; Pajtler KW
J Neurosurg Sci; 2018 Feb; 62(1):46-50. PubMed ID: 28895660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
